Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
435 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03541161 | Early Rehabilitation After Immediate Reconstruction With TEI in Breast Cancer Patients | completed | — | 115 | Samsung Medical CenterOTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT02632864 | Feasibility of High Dose PROton Therapy On Unresectable Primary Carcinoma Of Liver: Prospective Phase II Trial | unknown | Phase 2 | 66 | Samsung Medical CenterOTHER | 1 | Apr 12, 2018 | clinicaltrials |
| NCT03439709 | Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma(MERGE) | unknown | Phase 3 | 90 | Samsung Medical CenterOTHER | 1 | Mar 1, 2018 | clinicaltrials |
| NCT03240562 | Ultrasound-guided Block for Thoracic Surgery Pain | completed | N/A | 89 | Samsung Medical CenterOTHER | 1 | Feb 28, 2018 | clinicaltrials |
| NCT03424759 | Uncommon EGFR AZD9291 | unknown | Phase 2 | 37 | Samsung Medical CenterOTHER | 1 | Feb 7, 2018 | clinicaltrials |
| NCT02591966 | Genetic Alteration After Systemic Treatment in Breast Cancer | unknown | — | 350 | Samsung Medical CenterOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT01299688 | HER2 Circulating Tumor Cells in Gastric Cancer | completed | — | 135 | Samsung Medical CenterOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT01470404 | Pharmacogenomic Study (Adjuvant Chemotherapy) | completed | — | 792 | Samsung Medical CenterOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT02015169 | Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis | completed | Phase 2 | 32 | Samsung Medical CenterOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT02026583 | A Single Arm, Phase II Study of Simvastatin Plus XELOX and Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer Patients | completed | Phase 2 | 43 | Samsung Medical CenterOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT02449564 | The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid Tumors | completed | N/A | 5 | Samsung Medical CenterOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT03401359 | The Resistance and Immune Response to Palbociclib in Breast Cancer | unknown | N/A | 100 | Samsung Medical CenterOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT03399669 | The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation | unknown | Phase 2 | 100 | Samsung Medical CenterOTHER | 1 | Jan 16, 2018 | clinicaltrials |
| NCT03366376 | Hippocampus-sparing WBRT and Simultaneous Integrated Boost for Multiple Brain Metastases From NSCLC(KROG17-06) | unknown | Phase 2 | 80 | Samsung Medical CenterOTHER | 1 | Dec 8, 2017 | clinicaltrials |
| NCT03356678 | Pralatrexate for Relapsed or Refractory Peripheral T-cell Lymphoma | completed | — | 33 | Samsung Medical CenterOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT01311232 | Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab | completed | — | 600 | Samsung Medical CenterOTHER | 4 | Oct 27, 2017 | clinicaltrials |
| NCT01877109 | Samsung Medical Center-Lymphoma Cohort Study-II(SMC-LCS-II) | completed | — | 1,358 | Samsung Medical CenterOTHER | 1 | Oct 27, 2017 | clinicaltrials |
| NCT03219554 | A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor | unknown | Phase 2 | 33 | Samsung Medical CenterOTHER | 1 | Aug 2, 2017 | clinicaltrials |
| NCT03142542 | The Efficacy and Safety of Udenafil in Patients With Erectile Dysfunction After Bilateral Nerve-sparing Radical Prostatectomy(DA8159_EDP_IIT) | unknown | Phase 4 | 99 | Samsung Medical CenterOTHER | 0 | May 5, 2017 | clinicaltrials |
| NCT00561119 | Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast Cancer | completed | Phase 3 | 326 | Samsung Medical CenterOTHER | 1 | May 1, 2017 | clinicaltrials |
| NCT00816634 | Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma(XP versus XT) | unknown | Phase 2 | 94 | Samsung Medical CenterOTHER | 1 | May 1, 2017 | clinicaltrials |
| NCT01266213 | Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women(FLAG) | unknown | Phase 2 | 147 | Samsung Medical CenterOTHER | 1 | May 1, 2017 | clinicaltrials |
| NCT01273415 | Usefulness of Ki67 Index in Hormone Receptor-positive Breast Cancer | completed | — | 1,070 | Samsung Medical CenterOTHER | 1 | May 1, 2017 | clinicaltrials |
| NCT02063906 | Prognostic Relevance of Biological Subtype in Breast Cancer | unknown | — | 202 | Samsung Medical CenterOTHER | 1 | May 1, 2017 | clinicaltrials |
| NCT02597179 | Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer | unknown | — | 350 | Samsung Medical CenterOTHER | 1 | May 1, 2017 | clinicaltrials |
| NCT02670603 | A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis | completed | N/A | 100 | Samsung Medical CenterOTHER | 1 | Apr 28, 2017 | clinicaltrials |
| NCT02060669 | Xeloda Maintenance Versus BSC in Metastatic Colorectal Cancer | terminated | Phase 3 | 10 | Samsung Medical CenterOTHER | 1 | Apr 27, 2017 | clinicaltrials |
| NCT03131089 | Young Breast Cancer Cohort Study(YBC) | unknown | — | 2,000 | Samsung Medical CenterOTHER | 1 | Apr 27, 2017 | clinicaltrials |
| NCT01481805 | Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients | completed | — | 100 | Samsung Medical CenterOTHER | 1 | Apr 26, 2017 | clinicaltrials |
| NCT01538238 | pazopanib_NCRCC,Ph2 STUDY | completed | Phase 2 | 10 | Samsung Medical CenterOTHER | 1 | Apr 26, 2017 | clinicaltrials |
| NCT02346032 | Phase II Study of Refametinib, a MEK Inhibitor, as Second-line Treatment in Advanced Biliary Tract Adenocarcinoma | completed | Phase 2 | 4 | Samsung Medical CenterOTHER | 0 | Apr 26, 2017 | clinicaltrials |
| NCT02386813 | International Extranodal NK/T-cell Lymphoma Project(PINK) | completed | — | 770 | Samsung Medical CenterOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT02450149 | Single-arm Study to Evaluate the Safety and Efficacy of Sorafenib, in Subjects With BRAF Mutation Refractory Solid Tumors | completed | N/A | 1 | Samsung Medical CenterOTHER | 1 | Mar 13, 2017 | clinicaltrials |
| NCT02029326 | Biomarker Analysis in Metastatic Colorectal Cancer Treated With Cetuximab | completed | — | 30 | Samsung Medical CenterOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00944463 | Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients | completed | Phase 2 | 106 | Samsung Medical CenterOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT01099085 | Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients | completed | Phase 3 | 207 | Samsung Medical CenterOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT01469611 | A Trial of JX-594 in Refractory Colorectal Carcinoma | completed | Phase 1 | 15 | Samsung Medical CenterOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT02342587 | Safety and Clinical Activity of Lapatinib in Patients With HER2-positive Refractory Advanced Cancer | completed | Phase 2 | 7 | Samsung Medical CenterOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT02435108 | A Pilot Study of Crizotinib in Patients With c-MET Positive Gastric Adenocarcinoma as a Third-line Chemotherapy | completed | Phase 2 | 2 | Samsung Medical CenterOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT02449538 | Study to Evaluate the Safety and Efficacy of Everolimus, in Subjects With PIK3CA Amplification, PTEN Loss and PIK3CA Mutation Refractory Solid Tumors | completed | Phase 2 | 10 | Samsung Medical CenterOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT03053856 | Adjuvant Pembrolizumab in N2 Positive Non-small Cell Lung Cancer Patients | unknown | Phase 2 | 37 | Samsung Medical CenterOTHER | 1 | Feb 15, 2017 | clinicaltrials |
| NCT03050437 | A Study Comparing Pemetrexed Plus Cisplatin Versus Pemetrexed Alone in NSCLC Patients Who Have Progressed on First Line EGFR-TKI | unknown | Phase 2 | 96 | Samsung Medical CenterOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT02599012 | The Efficacy of Intravenous Iron for the Treatment of Anemia in Cancer Patients | unknown | Phase 2 | 100 | Samsung Medical CenterOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT02967146 | Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®) After Axillary Dissection for Breast Cancer | unknown | Phase 3 | 170 | Samsung Medical CenterOTHER | 1 | Jan 5, 2017 | clinicaltrials |
| NCT02963688 | BRCA 1/2 Mutation in Korean Patients With Epithelial Ovarian Cancer | completed | — | 298 | Samsung Medical CenterOTHER | 0 | Nov 15, 2016 | clinicaltrials |
| NCT00793351 | Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation | completed | Phase 2 | 25 | Samsung Medical CenterOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT02644993 | Registry for Analysis of Quality of Life, Normal Organ Toxicity and Survival of Pediatric Patients Treated With Proton Therapy | unknown | N/A | 400 | Samsung Medical CenterOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT02331056 | Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy? | completed | — | 79 | Samsung Medical CenterOTHER | 1 | Oct 7, 2016 | clinicaltrials |
| NCT02781259 | Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer | unknown | Phase 4 | 150 | Samsung Medical CenterOTHER | 1 | Sep 20, 2016 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials